Literature DB >> 6328543

The effects of delta 9-tetrahydrocannabinol on serum thyrotropin levels in the rat.

C J Hillard, N E Farber, T C Hagen, A S Bloom.   

Abstract

The effects of acute treatment with delta 9-tetrahydrocannabinol (delta 9-THC) on serum levels of thyrotropin (TSH) and the thyroid hormones triiodothyronine (T3) and thyroxine (T4) were determined in the rat. Intraperitoneal doses of delta 9-THC greater than 3 mg/kg reduced serum TSH levels to less than 10% of control. The ED50 for delta 9-THC was approximately 0.3 mg/kg. After a 10 mg/kg dose of delta 9-THC, the maximum decrease in serum TSH occurred at one hour. Both serum T3 and serum T4 levels were decreased by a single 10 mg/kg delta 9-THC injection with maximal decreases at 6 hr post-injection. The effects of delta 9-THC on the ability of thyrotropin releasing hormone (TRH) to increase serum TSH and T3 were determined. TRH produced a 10-fold increase in serum TSH levels and this increase was unaffected by delta 9-THC pretreatment. Serum T3 levels were slightly increased by TRH and this increase was also unaffected by delta 9-THC. These findings indicate that acute treatment with delta 9-THC results in a decrease in circulating TSH, T3 and T4 levels but has no effect on the pituitary or thyroid response to exogenous TRH.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6328543     DOI: 10.1016/0091-3057(84)90303-4

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  6 in total

Review 1.  Endocannabinoids and the Endocrine System in Health and Disease.

Authors:  Cecilia J Hillard
Journal:  Handb Exp Pharmacol       Date:  2015

2.  Type 1 cannabinoid receptor-containing axons innervate hypophysiotropic thyrotropin-releasing hormone-synthesizing neurons.

Authors:  Levente Deli; Gábor Wittmann; Imre Kalló; Ronald M Lechan; Masahiko Watanabe; Zsolt Liposits; Csaba Fekete
Journal:  Endocrinology       Date:  2008-09-25       Impact factor: 4.736

Review 3.  The effects of cannabis and cannabinoids on the endocrine system.

Authors:  Farah Meah; Michelle Lundholm; Nicholas Emanuele; Hafsa Amjed; Caroline Poku; Lily Agrawal; Mary Ann Emanuele
Journal:  Rev Endocr Metab Disord       Date:  2021-08-30       Impact factor: 9.306

Review 4.  Endocannabinoids in Body Weight Control.

Authors:  Henrike Horn; Beatrice Böhme; Laura Dietrich; Marco Koch
Journal:  Pharmaceuticals (Basel)       Date:  2018-05-30

5.  Graphene-modified CePO4 nanorods effectively treat breast cancer-induced bone metastases and regulate macrophage polarization to improve osteo-inductive ability.

Authors:  Yu-Wei Ge; Xiao-Liang Liu; De-Gang Yu; Zhen-An Zhu; Qin-Fei Ke; Yuan-Qing Mao; Ya-Ping Guo; Jing-Wei Zhang
Journal:  J Nanobiotechnology       Date:  2021-01-07       Impact factor: 10.435

6.  Targeting the Endocannabinoid System in Borderline Personality Disorder: Corticolimbic and Hypothalamic Perspectives.

Authors:  Sari G Ferber; Reut Hazani; Gal Shoval; Aron Weller
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.